| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Function
1) this product can only be used for intravenous injection, because of venous irritation, can cause thrombophlebitis, it should not drip. If redness, pain or spills, immediately stop and take appropriate measures, such as a cold compress.
2)can not be performed during the FDA radiotherapy, especially thoracic radiotherapy. Disable least 3-4 weeks after radiotherapy to apply daunorubicin.
3) during the treatment and should be monitored before each chemotherapy, blood and heart function, regular liver and kidney function tests.
4)the product in animals can cause reproductive dysfunction and obstacles delayed. In male dogs can cause testicular atrophy.
Application of Daunorubicin HCl
| Item | Test Standard | Testing Result | |
| Assay | 99% | Complies | |
| Apperence | Red Powder | Complies | |
| Particle Size | 100% pass 80 mesh | Complies | |
| Oder | Characteristic | Complies | |
| Taste | Characteristic | Complies | |
| Loss on Drying | ≤5.0% | 2.20% | |
| Residue on Ignition | ≤0.1% | 0.05% | |
| Residual | ≤0.1% | Complies | |
| Residual Ethanol | ≤0.5% | Complies | |
| Heave Mentals | ≤10ppm | Complies | |
| Na | ≤0.1% | <0.1% | |
| Pb | ≤3 ppm | Complies | |
| Total Plate | <1000CFU/g | Complies | |
| Yeast & Mold | <100 CFU /g | Complies | |
| E. Coli | Negative | Complies | |
| Salmonella | Negative | Complies | |
){kind=link}